Tag: Kairos Ventures
Vivodyne lands $38m to transform drug development with lab-grown human organs
Vivodyne, a biotech company focused on developing more effective drugs tested on lab-grown human organs, announced a colossal close of $38 million in total seed ... Read More
Pinpoint Therapeutics secures funds for developing autophagy inhibitors for cancer
Pinpoint Therapeutics, a US biopharma company focused on developing autophagy inhibitors for cancer treatment, has secured $1 million in debt financing led by California-based venture ... Read More